Antiviral Drug Market Size

Antiviral Drug Market Size, Share Outlook Growth by Top Company, Development, Application, Segmentation, Trends and Forecast 2020-2025

  • Report ID: BMRC 681 | Number of pages: 200 | Publish Date: Feb 2020
    Status: Published | Category: Pharmaceutical | Delivery Timeline: 48 hrs


COVID-19
To know the impact of COVID-19 On Antiviral Drug Market Size, Share Outlook Growth by Top Company, Development, Application, Segmentation, Trends and Forecast 2020-2025 Market

Request Now

Market Size Graph


Antiviral Drug Market applies the most effective of each primary and secondary analysis to weighs upon the competitive landscape and also the outstanding market players expected to dominate Antiviral Drug Market place for the forecast 2019– 2025.

Scope of The Antiviral Drug Market Report:

Rising occurrence of viral infections such as hepatitis, HIV, influenza, and respiratory syncytial virus is predicted to power the requirement for antiviral drugs. This is predicted to power the requirement for antiviral drugs and efficient treatment solutions.

Antiviral drugs reside in the class of medications, which are employed for treating viral infections, such as herpes, HIV, influenza, and hepatitis. These drugs are normally administered in vaccines form. Moreover, most of these drugs are employed for particular viral infections, while a few are effective in opposition to a wide series of viruses.

The global antiviral drug market is divided by type, mechanism of action, region, and application. By mechanism of action, it is segmented into protease inhibitors, reverse transcriptase inhibitors, nucleotide polymerase inhibitors, and others. By type, it is divided into branded drugs and generic drugs. By application, it is divided into hepatitis, HIV, influenza, herpes, and other viral diseases. The market is segmented by region across Europe (France, Spain, Germany, Italy, UK, and rest of Europe), North America (Canada, U.S., and Mexico), LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA), and Asia-Pacific (South Korea, China, Japan, Australia, India, and rest of Asia-Pacific).

Antiviral Drug Top Companies

The major players included in the global antiviral drug market forecast are,

  • Gilead Sciences
  • F. Hoffmann-La Roche Ltd
  • Bristol-Myers-Squibb
  • GlaxoSmithKline
  • AstraZeneca plc.
  • Abbott Laboratories
  • Schering-Plough Corporation
  • AbbVie Inc.
  • Merck & Co., Inc.
  • Johnson & Johnson.

 

 

Antiviral Drug Market Key Market Segments:

By Mechanism of Action: Nucleotide Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Others

By Type: Generic, Branded

By Application: HIV, Hepatitis, Herpes, Influenza, Others

The Global Antiviral drug market Is Powered By Rise In The Occurrence Rate Of Viral Infections

The global antiviral drug market is powered by rise in the occurrence rate of viral infections. Moreover, increase in R&D activities and development of advanced & newer formulations, such as combination therapy and vaccines, are predicted to power the growth of the market. On the other hand, high price involved in drug growth and development in the requirement for substitute medicines such as homeopathy and naturopathy restrain the market development. In addition to this, growth opportunities in the emerging nations of LAMEA and Asia Pacific areas and development of broad-spectrum antibiotics are predicted to offer various opportunities for the growth of the market during the coming period. Rising occurrence of viral infections such as hepatitis, HIV, influenza, and respiratory syncytial virus (RSV) is predicted to power the requirement for antiviral drugs. For example, as per data posted by the WHO, hepatitis B led to almost 887,000 deaths in 2015. In addition to this, it was predicted that almost 257 million people in 2015 were suffering from hepatitis B virus (HBV) infection. This is predicted to power the requirement for antiviral drugs and efficient treatment solutions.

Factors such as drop in the cost of US Medicare and competitive dynamics hamper the requirement for antiviral drugs. Moreover, rising awareness about the availability of viral infections’ vaccines and preventive measures will be restraint to the development of antiviral drug market.

North America Led The Global Market With A Huge Share Due To The Attendance Of Major Players In The Area

North America led the global market with a huge share due to the attendance of major players in the area, increasing awareness of viral diseases, and availability of sophisticated healthcare infrastructure. Improving economic stability, increasing patient pool, and the attendance of established & strong generic drugs market in South Asian nations are some of the major factors predicted to offer the market in Asia Pacific with growth avenues. In addition to this, Middle East & Africa is predicted to be one of the quickest developing regions due to rising cases of diseases in nations such as UAE, Qatar, and Saudi Arabia.

Market by Regional Analysis

North America (USA, Canada, Mexico), Europe (UK, France, Germany, Russia, Rest of Europe), Asia-Pacific (China, South Korea, India, Japan, Rest of Asia-Pacific), LAMEA, Latin America, Middle East, Africa


Interested in this report?

Antiviral Drug Market 2020 Latest Innovations, Key Players and Competitive Strategies – Forecast to 2025 and Analysis 2019-2025

report cover

Table of Content

Chapter 1 Global Antiviral Drug Market: Summary and Quantitative Analysis 
1.1 Report Description 
1.2 Global Antiviral Drug Market Revenue Overview 
1.3 Global Antiviral Drug Market Revenue (USD Billion) and Growth (%) Rate, 2015- 2025
 
Chapter 2 Global Antiviral Drug Market: Overview and Qualitative Analysis 
2.1 Executive Summary 
2.2 Market Drivers 
2.2.1 Increasing need to improve the process in order to comply with new standards is anticipated to witness a high growth of Antiviral Drug Market 
2.3 Market Restraints 
2.4 Market Opportunities 
2.5 Market Trends 
2.6 Global Antiviral Drug Market: SWOT Analysis 
2.7 Global Antiviral Drug Market: PEST Analysis 
2.8 Global Antiviral Drug Market: Attractiveness Analysis 
2.8.1 Global Antiviral Drug Market: Attractiveness Analysis by Type 
2.8.2 Global Antiviral Drug Market: Attractiveness Analysis by Grade 
2.8.3 Global Antiviral Drug Market: Attractiveness Analysis by Regional 

Chapter 3 Competitive Analysis 
3.1 Global Antiviral Drug Market 
3.1.1 Global Antiviral Drug market Revenue (USD Billion), By Players 2018 
3.1.2 Global Antiviral Drug Market Revenue Share (%), By Players 2018 

Chapter 5 Global Antiviral Drug Market: By Types 
5.1 Global Antiviral Drug Market Share (%), By Types, 2018 
5.2 Global Antiviral Drug Market Revenue (USD Billion), By Types, 2015 – 2025 
5.3 Global Antiviral Drug Market Revenue (USD Billion), Based,2015-2025 
5.4 Global Antiviral Drug Market Revenue (USD Billion), Based,2015-2025 
5.5 Global Antiviral Drug Market Revenue Share (%), By Types, 2015 – 2025 
5.6 Global Antiviral Drug Market Revenue Market Share (%), By Types, 2015-2025 

Chapter 6 Global Antiviral Drug Market: By Application 
6.1 Global Antiviral Drug Market Share (%), By Application, 2018 
6.2 Global Antiviral Drug Market Revenue (USD Billion), By Application, 2015 – 2025 
6.3 Global Antiviral Drug Market Revenue (USD Billion), Enterprises, 2015-2025 
6.4 Global Antiviral Drug Market Revenue (USD Billion),2015-2025 
6.5 Global Antiviral Drug Market Revenue Share (%), By Application, 2015 – 2025 
6.6 Global Antiviral Drug Market Revenue Market Share (%), By Application, 2015-2025 

Chapter 7 North America Antiviral Drug Market Analysis 
7.1 North America Market Snapshot 
7.1.1 North America Antiviral Drug Market Revenue and Growth Rate (%), 2015-2025. 
7.1.2 North America Antiviral Drug Market Revenue (USD Billion) Overview, by Country, 2015 – 2025 
7.1.3 North America Antiviral Drug Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
7.1.4 North America Antiviral Drug  Revenue (USD Billion) Overview, by Type, 2015-2025 
7.1.5 North America Antiviral Drug  Revenue (USD Billion) Overview, by Types, 2015-2025 
7.1.6 North America Antiviral Drug  Revenue (USD Billion) Overview, by Application , 2015-2025 

Chapter 8 Europe Antiviral Drug Market Analysis 
8.1 Europe Market Snapshot 
8.1.1 Europe Antiviral Drug Market Revenue and Growth Rate (%), 2015-2025. 
8.1.2 Europe Antiviral Drug Market Revenue (USD Billion) Overview, by Country, 2015 – 2025 
8.1.3 Europe Antiviral Drug Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025. 
8.1.4 Europe Antiviral Drug  Revenue (USD Billion) Overview, by Type, 2015-2025 
8.1.5 Europe Antiviral Drug  Revenue (USD Billion) Overview, by Types, 2015-2025 
8.1.6 Europe Antiviral Drug  Revenue (USD Billion) Overview, by Application, 2015-2025 

Chapter 9 Asia Pacific Antiviral Drug Market Analysis 
9.1 Asia Pacific Market Snapshot 
9.1.1 Asia Pacific Antiviral Drug Market Revenue and Growth Rate (%), 2015-2025. 
9.1.2 Asia Pacific Antiviral Drug Market Revenue (USD Billion) Overview, by Country, 2015 – 2025 
9.1.3 Asia Pacific Antiviral Drug Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025. 
9.1.4 Asia Pacific Antiviral Drug  Revenue (USD Billion) Overview, by Type, 2015-2025 
9.1.5 Asia Pacific Antiviral Drug  Revenue (USD Billion) Overview, by Types, 2015-2025
9.1.6 Asia Pacific Antiviral Drug  Revenue (USD Billion) Overview, by Application, 2015-2025 

Chapter 10 Latin America Antiviral Drug Market Analysis 
10.1 Latin America Market Snapshot 
10.1.1 Latin America Antiviral Drug Market Revenue and Growth Rate (%), 2015-2025. 
10.1.2 Latin America Antiviral Drug Market Revenue (USD Billion) Overview, by Country, 2015 – 2025 
10.1.3 Latin America Antiviral Drug Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025. 
10.1.4 Latin America Antiviral Drug  Revenue (USD Billion) Overview, by Type, 2015-2025 
10.1.5 Latin America Antiviral Drug  Revenue (USD Billion) Overview, by Types, 2015-2025 
10.1.6 Latin America Antiviral Drug  Revenue (USD Billion) Overview, by Application, 2015-2025 

Chapter 11 Middle East & Africa Antiviral Drug Market Analysis
11.1 Middle East & Africa Market Snapshot 
11.1.1 Middle East & Africa Antiviral Drug Market Revenue and Growth Rate (%), 2015-2025. 
11.1.2 Middle East & Africa Antiviral Drug Market Revenue (USD Billion) Overview, by Country, 2015 – 2025 
11.1.3 Middle East & Africa Antiviral Drug Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025. 
11.1.4 Middle East & Africa Antiviral Drug  Revenue (USD Billion) Overview, by Type, 2015-2025 
11.1.5 Middle East & Africa Antiviral Drug  Revenue (USD Billion) Overview, by Types, 2015-2025 
11.1.6 Middle East & Africa Antiviral Drug  Revenue (USD Billion) Overview, by Application, 2015-2025 

Chapter 12 Competitive Analysis 
12.1 COMPANY 1. 
12.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
12.1.2 COMPANY 1. Total Company Revenue 2015-2018 
12.1.3 COMPANY 1. Total Company Revenue, By Segment of Business 2015-2018 
12.1.4 COMPANY 1. Total Company Revenue, By Region 2015-2018 
12.1.5 COMPANY 1. Global Antiviral Drug Product Category and Description 
12.1.6 COMPANY 1. Recent Activity 2015-2019 
12.1.7 Main Business/Business Overview 
12.1.8 Business Strategy 
12.1.9 SWOT Analysis 
12.2 Company 2. 
12.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
12.2.2 Company 2. Total Company Revenue 2015-2018 117
12.2.3 Company 2. Total Company Revenue, By Segment of Business 2015-2018
12.2.4 Company 2. Total Company Revenue, By Region 2015-2018 
12.2.5 Company 2. Global Antiviral Drug Product Category and Description 
12.2.6 Company 2. Recent Activity 2015-2019 
12.2.7 Main Business/Business Overview 
12.2.8 Business Strategy 
12.2.9 SWOT Analysis 
12.3 COMPANY 3 
12.3.1 Business Overview 
12.3.2 COMPANY 3 Market Product Category and Description & Specification 
12.3.3 Main Business/Business Overview 
12.3.4 Business Strategy 
12.3.5 SWOT Analysis 
12.4 COMPANY 4 
12.4.1 Business Overview 
12.4.2 COMPANY 4 Company Total Company Revenue 2015-2018 
12.4.3 COMPANY 4 Company Total Company Revenue, By Segment of Business 2015-2018 
12.4.4 COMPANY 4 Company Total Company Revenue, By Region of Business 2015-2018 
12.4.5 COMPANY 4 Company Product Category, Specification and Description 
12.4.6 COMPANY 4 Company Recent Mergers & Acquisitions (M&A) Activity 2015-2019 
12.4.7 COMPANY 4 Company Main Business/Business Overview 
12.4.8 Business Strategy 
12.4.9 SWOT Analysis 
12.5 Company 5 
12.5.1 Business Overview 
12.5.2 Company 5 Company Net Sales 2015-2018 
12.5.3 Company 5 Company Net Sales, By Segment of Business 2011-2018 
12.5.4 Company 5 Company Net Sales, By Region 2015-2018 
12.5.5 Company 5  Antiviral Drug Market Product Category and Specification 
12.5.6 COMPANY 5 Recent Mergers & Acquisitions (M&A) Activity 2015-2019 
12.5.7 COMPANY 5 Main Business/Business Overview 
12.5.8 Business Strategy 
12.5.9 SWOT Analysis 
12.6 Company 6 
12.6.1 Business Overview 
12.6.2 Company 6 Antiviral Drug Market Product Category and Specification 
12.6.3 Company 6 Recent Mergers & Acquisitions (M&A) Activity 2015-2019 
12.6.4 Company 6 Main Business/Business Overview 
12.6.5 Business Strategy 
12.6.6 SWOT Analysis 
12.7 Company 7 
12.7.1 Business Overview 
12.7.2 Company 7 Total Company Revenue 2015-2018 
12.7.3 Company 7 Total Company Revenue, By Segment of Business 2015-2018 
12.7.4 Company 7 Antiviral Drug Market Product Category and Description 
12.7.5 Company 7 Recent Mergers &Acquisitions (M&A) Activity 2015-2019 
12.7.6 Company 7 Main Business/Business Overview 
12.7.7 Business Strategy 
12.7.8 SWOT Analysis 

Chapter 13 Market Research  Findings & Conclusion 

Chapter 14 Research Methodology 
14.1 Research Process 
14.2 Primary Research 
14.3 Secondary Research 
14.4 Market Size Estimates 
14.5 Forecast Model 
14.7 Who is This Report For? 
14.8 USP’s of Report 

List of Figures 

FIG. 1 Global Antiviral Drug Market Revenue (USD Billion) and Growth Rate (%), 2015- 2025 
FIG. 3 Global Antiviral Drug Market: Attractiveness Analysis by Type 
FIG. 4 Global Antiviral Drug Market: Attractiveness Analysis by Types 
FIG. 5 Global Antiviral Drug Market: Attractiveness Analysis by Application 
FIG. 6 Global Antiviral Drug  Market: Attractiveness Analysis by Regional 
FIG. 7 Global Antiviral Drug Market 
FIG. 8 Global Antiviral Drug Market Share (%), By Type, 2018 
FIG. 9 Global Antiviral Drug Market Revenue (USD Billion), 
FIG. 10 Global Antiviral Drug Market Revenue (USD Billion), 
FIG. 11 Global Antiviral Drug Market Revenue Market Share (%), By Type, 2015-2025 
FIG. 12 Global Antiviral Drug Market Share (%), By Types, 2018 
FIG. 13 Global Antiviral Drug Market Revenue (USD Billion), 2015-2025 
FIG. 14 Global Antiviral Drug Market Revenue (USD Billion), 2015-2025 
FIG. 15 Global Antiviral Drug Market Revenue Market Share (%), By Types, 2015-2025 
FIG. 16 Global Antiviral Drug Market Share (%), By Application, 2018 
FIG. 17 Global Antiviral Drug Market Revenue (USD Billion), By Large Enterprises, 2015-2025 
FIG. 18 Global Antiviral Drug Market Revenue (USD Billion), 2015-2025 
FIG. 19 Global Antiviral Drug Market Revenue Market Share (%), By Application, 2015-2025 
FIG. 20 North America Antiviral Drug Market Revenue (USD Billion) and Growth Rate (%), 2015-2025. 
FIG. 21 North America Antiviral Drug Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025. 
FIG. 22 Europe Antiviral Drug Market Revenue (USD Billion) and Growth Rate (%), 2015-2025. 
FIG. 23 Europe Antiviral Drug Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025. 
FIG. 24 Asia Pacific Antiviral Drug Market Revenue (USD Billion) and Growth Rate (%), 2015-2025. 
FIG. 25 Asia Pacific Antiviral Drug Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025. 
FIG. 26 Latin America Antiviral Drug Market Revenue (USD Billion) and Growth Rate (%), 2015-2025. 
FIG. 27 Latin America Antiviral Drug Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
FIG. 28 Middle East & Africa Antiviral Drug Market Revenue (USD Billion) and Growth Rate (%), 2015-2025. 
FIG. 29 Middle East & Africa Antiviral Drug Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025. 
FIG. 30 COMPANY 1. Total Company Revenue 2015-2018 (USD Million, R & D Expenses %) 
FIG. 31 COMPANY 1. Total Company Revenue, by Segment of Business 2015-2018 (USD Million, AGR %) 
FIG. 32 COMPANY 1. Total Company Revenue, by Region 2015-2018 (USD Million, AGR %) 
FIG. 33 Company 2. Total Company Revenue 2015-2018 (USD Million) 
FIG. 34 Company 2. Total Company Revenue, by Segment of Business 2015-2018 (USD Million, AGR %) 
FIG. 35 Company 2. Total Company Revenue, by Region 2015-2018 (USD Million, AGR %) 
FIG. 36 COMPANY 4 Company Total Company Revenue 2015-2018 (USD Million) 
FIG. 37 COMPANY 4 Company Total Company Revenue, by Segment of Business 2015-2018 (USD Million, AGR %) 
FIG. 38 COMPANY 4 Company Total Company Revenue, by Region of Business 2015-2018 (USD Million, AGR %) 
FIG. 39 Company 5 Company Net Sales 2015-2018 (USD Million, R & D Expenses %) 
FIG. 40 Company 5 Company Net Sales, by Segment of Business 2015-2018 (USD Million, AGR %) 
FIG. 41 Company 5 Company Net Sales, by Region 2015-2018 (USD Million, AGR %) 
FIG. 42 Company 7 Total Company Revenue 2015-2018 (USD Million, R & D Expenses %) 
FIG. 43 Company 7 Total Company Revenue, by Segment of Business 2015-2018 (USD Million, AGR %) 
FIG. 44 Primary Research 
FIG. 45 Sources of Secondary Research 
FIG. 46 Forecast Model 

List of Tables

TABLE 1 Global Antiviral Drug Market Overview 
TABLE 2 Market Driver Impact Analysis 
TABLE 3 Market Restraints Impact Analysis 
TABLE 4 Global Antiviral Drug market Revenue (USD Billion), By Players2018 
TABLE 5 Global Antiviral Drug market Revenue Market share (%), By Players- 2018 
TABLE 6 Global Antiviral Drug Market Revenue (USD Billion), By Product Type, 2015 - 2025 
TABLE 7 Global Antiviral Drug Market Revenue Share (%), By Type, 2015 - 2025 
TABLE 8 Global Antiviral Drug Market Revenue (USD Billion), By Types, 2015 - 2025 
TABLE 9 Global Antiviral Drug Market Revenue Share (%), By Types, 2015 - 2025 
TABLE 10 Global Antiviral Drug Market Revenue (USD Billion), By Application, 2015 - 2025 
TABLE 11 Global Antiviral Drug Market Revenue Share (%), By Application, 2015 - 2025 
TABLE 12 North America Antiviral Drug market Revenue (USD Billion), by Country, 2015 - 2025
TABLE 13 North America Antiviral Drug  Revenue (USD Billion), by Type, 2015-2025 
TABLE 14 North America Antiviral Drug  Revenue (USD Billion), by Types, 2015-2025 
TABLE 15 North America Antiviral Drug  Revenue (USD Billion), by Application , 2015-2025 
TABLE 16 Europe Antiviral Drug market Revenue (USD Billion), by Country, 2015 - 2025 
TABLE 17 Europe Antiviral Drug  Revenue (USD Billion), by Type, 2015-2025 
TABLE 18 Europe Antiviral Drug  Revenue (USD Billion), by Types, 2015-2025 
TABLE 19 Europe Antiviral Drug  Revenue (USD Billion), by Application, 2015-2025 
TABLE 20 Asia Pacific Antiviral Drug market Revenue (USD Billion), by Country, 2015 - 2025 
TABLE 21 Asia Pacific Antiviral Drug  Revenue (USD Billion), by Type, 2015-2025 
TABLE 22 Asia Pacific Antiviral Drug  Revenue (USD Billion), by Types, 2015-2025 
TABLE 23 Asia Pacific Antiviral Drug  Revenue (USD Billion), by Application, 2015-2025 
TABLE 24 Latin America Antiviral Drug market Revenue (USD Billion), by Country, 2015 - 2025 
TABLE 25 Latin America Antiviral Drug  Revenue (USD Billion), by Type, 2015-2025 
TABLE 26 Latin America Antiviral Drug  Revenue (USD Billion), by Types, 2015-2025 
TABLE 27 Latin America Antiviral Drug  Revenue (USD Billion), by Application, 2015-2025 
TABLE 28 Middle East & Africa Antiviral Drug market Revenue (USD Billion), by Country, 2015 - 2025
TABLE 29 Middle East & Africa Antiviral Drug  Revenue (USD Billion), by Type, 2015-2025 
TABLE 30 Middle East & Africa Antiviral Drug  Revenue (USD Billion), by Types, 2015-2025
TABLE 31 Middle East & Africa Antiviral Drug Revenue (USD Billion), by Application, 2015-2025 
TABLE 32 COMPANY 1.  Basic Information, Manufacturing Base, Sales Area and Its Competitors 
TABLE 33 Company 2. Basic Information, Manufacturing Base, Sales Area and Its Competitors
TABLE 34 COMPANY 4 Basic Information, Manufacturing Base and Competitors 
TABLE 35 COMPANY 4 Company Basic Information, Manufacturing Base and Competitors 
TABLE 36 Company 5 Basic Information, Manufacturing Base and Competitors 
TABLE 37 Company 6 Basic Information, Manufacturing Base and Competitors 
TABLE 38 Company 7 Basic Information, Manufacturing Base and Competitors 

Antiviral Drug Market Size, Share Outlook Growth by Top Company, Development, Application, Segmentation, Trends and Forecast 2020-2025

  • Full Name * :
  • Bussiness Email * :
  • Job Title :
  • Company :
  • Contact No * :
  • Country * :
  • Any Query * :
  • Captcha * :
Note: For delivery of sample pages you must have a Domain Specific Email ID, normally your business email address complies. Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSNetc. are not accepted.
Choose License Type ( Price )

Single user license, allowing one specific user access to the product.
Multi-users license, allowing up to five users access to the product.
Corporte license . Allows all employees within your organization to access product.


American Express Citi Bank Credit/Debit Card Maestro Payment Master Card PayPal Visa Wire Transfer

+44-1173181773
alan@brandessenceresearch.biz


Looking for Regional Reports?